International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.
Fiche publication
Date publication
mai 2021
Journal
United European gastroenterology journal
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B, Kobayashi T, Olivera PA, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L
Lien Pubmed
Résumé
Fecal calprotectin (FC) is a non-invasive marker of gut inflammation which is frequently used to guide therapeutic decisions in patients with inflammatory bowel diseases (IBD). Each step of FC measurement can influence the results, leading to misinterpretations and potentially impacting the management of IBD patients. To date, there is high heterogeneity between FC measurements and no current method is universally accepted as a standard.
Mots clés
fecal calprotectin, inflammatory bowel disease, measurement, standardization
Référence
United European Gastroenterol J. 2021 May 7;: